12 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

PUREVUE™ Quick Connect Cannula System Tray; PUREVUE™ Quick Connect Cannula System Lid

FDA 510(k)
FDA Class 2 ·General Hospital

Unispace SA Cervical Cage

FDA 510(k)
FDA Class 2 ·Orthopedic

Stainless Turbine

FDA 510(k)
FDA Class 1 ·Dental

IMPLANT DRIVER EV (S) SHORT

FDA Adverse Event
Malfunction ·DENTSPLY IMPLANTS (A DIVISION OF DENTSPLY IH AB)·Product code NDP·April 20, 2026

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·October 14, 2022

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·October 14, 2022

COGNIS HE IS-1/DF-1/IS-1

FDA Adverse Event
Malfunction ·CARDIAC PACEMAKERS·Product code NIK·November 11, 2008

AFFINITY BED

FDA Adverse Event
Malfunction ·HILL-ROM INC.·Product code HDD·August 10, 2011

2520274-2013-04837

FDA Adverse Event
Injury ·SYNTHES USA·Product code HWC·July 30, 2013

NSK

FDA Adverse Event
Injury ·NAKANISHI INC.·Product code EFB·March 25, 2025

BARD Dynamic XT Deca Steerable, Product Number 201102, REPROCESSED ELECTROPHYSIOLOGY CATHETER

FDA Enforcement
Class II ·Ongoing·Stryker Sustainability Solutions·May 20, 2026

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014